Short Interest in Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Drops By 52.0%

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the target of a large decrease in short interest during the month of August. As of August 31st, there was short interest totaling 173,858 shares, a decrease of 52.0% from the August 15th total of 362,103 shares. Currently, 0.4% of the shares of the stock are sold short. Based on an average trading volume of 247,213 shares, the short-interest ratio is currently 0.7 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded Zhengye Biotechnology from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, July 20th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Zhengye Biotechnology Trading Down 2.5%

ZYBT traded down $0.04 during midday trading on Tuesday, hitting $1.39. The company had a trading volume of 21,305 shares, compared to its average volume of 1,966,191. Zhengye Biotechnology has a twelve month low of $0.62 and a twelve month high of $10.84. The company has a current ratio of 1.14, a quick ratio of 0.82 and a debt-to-equity ratio of 0.03. The firm’s 50-day simple moving average is $1.64 and its 200-day simple moving average is $1.14.

About Zhengye Biotechnology

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.